New risk factors for adult-onset incident asthma: A nested case-control study of host antioxidant defense

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 1, 2015, Pages 45-53

  Larkin, Emma K ^a   Gao, Yu Tang ^b   Gebretsadik, Tebeb ^a   Hartman, Terryl J ^c   Wu, Pingsheng ^a   Wen, Wanqing ^d   Yang, Gong ^d   Bai, Chunxue ^e   Jin, Meiling ^e   Roberts, L Jackson ^f   Gross, Myron ^g   Shu, Xiao O ^d   Hartert, Tina V ^a,d  

^a VANDERBILT UNIVERSITY   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c EMORY UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e FUDAN UNIVERSITY   (China)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Antioxidants; Asthma; Incidence study; Platelet activating factor acetylhydrolase; tocopherol

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALPHA TOCOPHEROL; ANTIOXIDANT; CAROTENE; ISOPROSTANE DERIVATIVE; LYCOPENE; SUPEROXIDE DISMUTASE; TOCOPHEROL; XANTHINE DERIVATIVE; BIOLOGICAL MARKER; THROMBOCYTE ACTIVATING FACTOR; TRACE ELEMENT;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; ASTHMA; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HOST RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; RISK FACTOR; BLOOD; CHINA; ENZYMOLOGY; IMMUNOLOGY; MIDDLE AGED; ONSET AGE; PHYSIOLOGY; PROSPECTIVE STUDY; PROTECTION; URINE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; AGE OF ONSET; AGED; ALPHA-TOCOPHEROL; ANTIOXIDANTS; ASTHMA; BIOMARKERS; CASE-CONTROL STUDIES; CHINA; F2-ISOPROSTANES; FEMALE; HUMANS; MICRONUTRIENTS; MIDDLE AGED; OXIDATIVE STRESS; PLATELET ACTIVATING FACTOR; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK FACTORS;

EID: 84920420104     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201405-0948OC     Document Type: Article

References (70)

1. Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003;21:177-186.
2. Riedl MA, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol 2008;8:49-56.
3. Devereux G, Seaton A. Diet as a risk factor for atopy and asthma. J Allergy Clin Immunol 2005;115:1109-1117, quiz 1118.
4. Bowler RP. Oxidative stress in the pathogenesis of asthma. Curr Allergy Asthma Rep 2004;4:116-122.
5. Wood LG, Gibson PG. Reduced circulating antioxidant defences are associated with airway hyper-responsiveness, poor control and severe disease pattern in asthma. Br J Nutr 2010;103:735-741.
6. Ahmad A, Shameem M, Husain Q. Relation of oxidant-antioxidant imbalance with disease progression in patients with asthma. Ann Thorac Med 2012;7:226-232.
7. Comhair SA, Xu W, Ghosh S, Thunnissen FB, Almasan A, Calhoun WJ, Janocha AJ, Zheng L, Hazen SL, Erzurum SC. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol 2005;166:663-674.
8. Fabian E, Pölöskey P, Kósa L, Elmadfa I, Réthy LA. Activities of antioxidant enzymes in relation to oxidative and nitrosative challenges in childhood asthma. J Asthma 2011;48:351-357.
9. Katsoulis K, Kontakiotis T, Gerou S, Kougioulis M, Lithoxopoulou H, Papakosta D. Alterations of erythrocyte superoxide dismutase activity in patients suffering from asthma attacks. Monaldi Arch Chest Dis 2010;73:99-104.
10. Smith LJ, Shamsuddin M, Sporn PH, Denenberg M, Anderson J. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med 1997;22:1301-1307.
11. Sackesen C, Ercan H, Dizdar E, Soyer O, Gumus P, Tosun BN, Büyüktuncer Z, Karabulut E, Besler T, Kalayci O. A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. J Allergy Clin Immunol 2008;122:78-85.
12. Ito S, Noguchi E, Shibasaki M, Yamakawa-Kobayashi K, Watanabe H, Arinami T. Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma. J Hum Genet 2002;47:99-101.
13. Mak JC, Leung HC, Ho SP, Law BK, Lam WK, Tsang KW, Ip MS, Chan-Yeung M. Systemic oxidative and antioxidative status in Chinese patients with asthma. J Allergy Clin Immunol 2004;114:260-264.
14. Stafforini DM, Numao T, Tsodikov A, Vaitkus D, Fukuda T, Watanabe N, Fueki N, McIntyre TM, Zimmerman GA, Makino S, et al. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest 1999;103:989-997.
15. Kruse S, Mao XQ, Heinzmann A, Blattmann S, Roberts MH, Braun S, Gao PS, Forster J, Kuehr J, Hopkin JM, et al. The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. Am J Hum Genet 2000;66:1522-1530.
16. Satoh N, Asano K, Naoki K, Fukunaga K, Iwata M, Kanazawa M, Yamaguchi K. Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. Am J Respir Crit Care Med 1999;159:974-979.
17. Allen S, Britton JR, Leonardi-Bee JA. Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis. Thorax 2009;64:610-619.
18. Riccioni G, Bucciarelli T, Mancini B, Di Ilio C, Della Vecchia R, D'Orazio N. Plasma lycopene and antioxidant vitamins in asthma: the PLAVA study. J Asthma 2007;44:429-432.
19. Wood LG, Garg ML, Smart JM, Scott HA, Barker D, Gibson PG. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr 2012;96:534-543.
20. Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Browne RW, McCann SE, Trevisan M, Cassano PA, Iacoviello L, et al. Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr 2006;60:991-999.
21. Sierra-Vargas MP, Guzman-Grenfell AM, Blanco-Jimenez S, Sepulveda-Sanchez JD, Bernabe-Cabanillas RM, Cardenas-Gonzalez B, Ceballos G, Hicks JJ. Airborne particulate matter PM2.5 from Mexico City affects the generation of reactive oxygen species by blood neutrophils from asthmatics: an in vitro approach. J Occup Med Toxicol 2009;4:17.
22. Wood LG, Garg ML, Powell H, Gibson PG. Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: proof of concept. Free Radic Res 2008;42:94-102.
23. Larkin EK, Pingsheng W, Tebeb G, Roberts LJ, Myron G, Tina H. Antioxidant defense and adult-onset incident asthma: the Shanghai Women's Asthma And Allergy Study [abstract]. Am J Respir Crit Care Med 2011;183:A3744.
24. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, Li HL, Wen W, Ji BT, Li Q, et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-1131.
25. Hartert TV, Deng X, Hartman TJ, Wen W, Yang G, Gao YT, Jin M, Bai C, Gross M, Roberts LJ II, et al. The Shanghai Women's Asthma and Allergy Study: objectives, design, and recruitment results. Am J Epidemiol 2008;167:1387-1396.
26. Davies SS, Zackert W, Luo Y, Cunningham CC, Frisard M, Roberts LJ II. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry. Anal Biochem 2006;348:185-191.
27. Bieri JG, Brown ED, Smith JC. Determination of individual carotenoids in human plasma by high performance liquid chromatography. J Liq Chromatogr 1985;8:473-484.
28. Craft NE, Brown ED, Smith JC Jr. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. Clin Chem 1988;34:44-48.
29. Stafforini DM, McIntyre TM, Prescott SM. Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol 1990;187:344-357.
30. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
31. National Center for Environmental Health, Division of Laboratory Sciences. Second national report on biochemical indicators of diet and nutrition in the US population. 2012 [accessed 2012 Dec 20]. Available from: http://www.cdc.gov/nutritionreport/pdf/Nutrition-Book-complete508-final.pdf
32. Péter S, Moser U, Pilz S, Eggersdorfer M, Weber P. The challenge of setting appropriate intake recommendations for vitamin E: considerations on status and functionality to define nutrient requirements. Int J Vitam Nutr Res 2013;83:129-136.
33. Ratnasinghe D, Tangrea JA, Forman MR, Hartman T, Gunter EW, Qiao YL, Yao SX, Barett MJ, Giffen CA, Erozan Y, et al. Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes Control 2000;11:129-135.
34. Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, Wang W, Blot WJ, Dong ZW, Mark SD. Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1414-1416.
35. Ford ES, Schleicher RL, Mokdad AH, Ajani UA, Liu S. Distribution of serum concentrations of alpha-tocopherol and gamma-tocopherol in the US population. Am J Clin Nutr 2006;84:375-383.
36. Elswick RK Jr, Schwartz PF, Welsh JA. Interpretation of the odds ratio from logistic regression after a transformation of the covariate vector. Stat Med 1997;16:1695-1703.
37. Wedes SH, Khatri SB, Zhang R, Wu W, Comhair SA, Wenzel S, Teague WG, Israel E, Erzurum SC, Hazen SL. Noninvasive markers of airway inflammation in asthma. Clin Transl Sci 2009;2:112-117.
38. Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 2000;162:1450-1454.
39. Wood LG, Garg ML, Blake RJ, Garcia-Caraballo S, Gibson PG. Airway and circulating levels of carotenoids in asthma and healthy controls. J Am Coll Nutr 2005;24:448-455.
40. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000;35:967-974.
41. Dworski R, Roberts LJ II, Murray JJ, Morrow JD, Hartert TV, Sheller JR. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy 2001;31:387-390.
42. Troisi RJ, Willett WC, Weiss ST, Trichopoulos D, Rosner B, Speizer FE. A prospective study of diet and adult-onset asthma. Am J Respir Crit Care Med 1995;151:1401-1408.
43. Varraso R, Kauffmann F, Leynaert B, Le Moual N, Boutron-Ruault MC, Clavel-Chapelon F, Romieu I. Dietary patterns and asthma in the E3N study. Eur Respir J 2009;33:33-41.
44. Berdnikovs S, Abdala-Valencia H, McCary C, Somand M, Cole R, Garcia A, Bryce P, Cook-Mills JM. Isoforms of vitamin E have opposing immunoregulatory functions during inflammation by regulating leukocyte recruitment. J Immunol 2009;182:4395-4405.
45. McCary CA, Abdala-Valencia H, Berdnikovs S, Cook-Mills JM. Supplemental and highly elevated tocopherol doses differentially regulate allergic inflammation: reversibility of α-tocopherol and γ-tocopherol's effects. J Immunol 2011;186:3674-3685.
46. Nwaru BI, Virtanen SM, Alfthan G, Karvonen AM, Genuneit J, Lauener RP, Dalphin JC, Hyvarinen A, Pfefferle P, Riedler J, et al.; PASTURE study group. Serum vitamin E concentrations at 1 year and risk of atopy, atopic dermatitis, wheezing, and asthma in childhood: the PASTURE study. Allergy 2014;69:87-94.
47. Hoskins A, Roberts JL II, Milne G, Choi L, Dworski R. Natural-source d-α-tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivo. Allergy 2012;67:676-682.
48. Ford ES, Mannino DM, Redd SC. Serum antioxidant concentrations among U.S. adults with self-reported asthma. J Asthma 2004;41:179-187.
49. Rubin RN, Navon L, Cassano PA. Relationship of serum antioxidants to asthma prevalence in youth. Am J Respir Crit Care Med 2004;169:393-398.
50. Karasawa, K. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta 2006;1761:1359-1372.
51. Adamus WS, Heuer HO, Meade CJ, Schilling JC. Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings. Clin Pharmacol Ther 1990;47:456-462.
52. Louis RE, Radermecker MF. Acute bronchial obstruction following inhalation of PAF in asthmatic and normal subjects: comparison with methacholine. Eur Respir J 1996;9:1414-1420.
53. Chung KF, Cuss FM, Barnes PJ. Platelet activating factor: effects on bronchomotor tone and bronchial responsiveness in human beings. Allergy Proc 1989;10:333-337.
54. Cuss FM, Dixon CM, Barnes PJ. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986;2:189-192.
55. Steiger J, Bray MA, Subramanian N. Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro. Eur J Pharmacol 1987;142:367-372.
56. Shouji K, Enzan K, Mitsuhata H, Yoshioka N. Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung. Shock 1998;9:412-415.
57. Evans DJ, Barnes PJ, Cluzel M, O'Connor BJ. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses. Am J Respir Crit Care Med 1997;156:11-16.
58. Freitag A, Watson RM, Matsos G, Eastwood C, O'Byrne PM. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. Thorax 1993;48:594-598.
59. Gómez FP, Roca J, Barberà JA, Chung KF, Peinado VI, Rodriguez-Roisin R. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. Eur Respir J 1998;11:835-839.
60. Gómez FP, Marrades RM, Iglesia R, Roca J, Barberà JA, Chung KF, Rodriguez-Roisin RM. Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study. Eur Respir J 1999;14:622-626.
61. Hozawa S, Haruta Y, Ishioka S, Yamakido M. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am J Respir Crit Care Med 1995;152:1198-1202.
62. Hsieh KH. Effects of PAF antagonist, BN52021, on the PAF-, methacholine-, and allergen-induced bronchoconstriction in asthmatic children. Chest 1991;99:877-882.
63. Inoue H, Aratani H, Takishima T, Kagoshima M, Iwahisa Y, Terasawa M. Effect of a potent PAF antagonist, Y-24180, on an allergen-induced late asthmatic response in guinea-pigs. J Lipid Mediat 1992;5:173-176.
64. Kuitert LM, Hui KP, Uthayarkumar S, Burke W, Newland AC, Uden S, Barnes NC. Effect of the platelet-activating factor antagonist UK-74,505 on the early and late response to allergen. Am Rev Respir Dis 1993;147:82-86.
65. Kuitert LM, Angus RM, Barnes NC, Barnes PJ, Bone MF, Chung KF, Fairfax AJ, Higenbotham TW, O'Connor BJ, Piotrowska B, et al. Effect of a novel potent platelet-activating factor antagonist, modipafant, in clinical asthma. Am J Respir Crit Care Med 1995;151:1331-1335.
66. Spence DP, Johnston SL, Calverley PM, Dhillon P, Higgins C, Ramhamadany E, Turner S, Winning A, Winter J, Holgate ST. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am J Respir Crit Care Med 1994;149:1142-1148.
67. Tamura G, Takishima T, Mue S, Makino S, Itoh K, Miyamoto T, Shida T, Nakajima S. Effect of a potent platelet-activating factor antagonist, WEB-2086, on asthma. A multicenter, double-blind placebo-controlled study in Japan. Adv Exp Med Biol 1996;416:371-380.
68. Tuncel T, Karaman M, Firinci F, Uysal P, Kiray M, Bagriyanik AH, Yilmaz O, Karaman O, Uzuner N. The effect of rupatadine on lung histopathology in a murine model of chronic asthma. J Asthma 2013;50:141-146.
69. Comhair SA, Ricci KS, Arroliga M, Lara AR, Dweik RA, Song W, Hazen SL, Bleecker ER, Busse WW, Chung KF, et al. Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med 2005;172:306-313.
70. Cook-Mills JM, Abdala-Valencia H, Hartert T. Two faces of vitamin E in the lung. Am J Respir Crit Care Med 2013;188:279-284.